1. Home
  2. Labeler Index
  3. Hf Acquisition Co Llc, Dba Healthfirst
  4. 51662-1449
  5. NDC Package Code: 51662-1449-1 Bumetanide

NDC Package 51662-1449-1 Bumetanide

Injection Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51662-1449-1
Package Description:
4 mL in 1 VIAL
Product Code:
51662-1449
Proprietary Name:
Bumetanide
Non-Proprietary Name:
Bumetanide
Substance Name:
Bumetanide
Usage Information:
Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. Bumetanide is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.
11-Digit NDC Billing Format:
51662144901
NDC to RxNorm Crosswalk:
  • RxCUI: 1727569 - bumetanide 1 MG in 4 ML Injection
  • RxCUI: 1727569 - 4 ML bumetanide 0.25 MG/ML Injection
  • RxCUI: 1727569 - bumetanide 1 MG per 4 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hf Acquisition Co Llc, Dba Healthfirst
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • BUMETANIDE .25 mg/mL
    • Pharmacologic Class(es):
  • Increased Diuresis at Loop of Henle - [PE] (Physiologic Effect)
  • Loop Diuretic - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA079196
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-11-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51662-1449-1?

    The NDC Packaged Code 51662-1449-1 is assigned to a package of 4 ml in 1 vial of Bumetanide, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. The product's dosage form is injection and is administered via intramuscular; intravenous form.

    Is NDC 51662-1449 included in the NDC Directory?

    Yes, Bumetanide with product code 51662-1449 is active and included in the NDC Directory. The product was first marketed by Hf Acquisition Co Llc, Dba Healthfirst on January 11, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51662-1449-1?

    The 11-digit format is 51662144901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151662-1449-15-4-251662-1449-01